These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
67 related items for PubMed ID: 16164210
1. [Osteoclastogenesis through TLR/NOD signaling]. Yamashita T, Yang S, Udagawa N. Nihon Rinsho; 2005 Sep; 63(9):1547-52. PubMed ID: 16164210 [Abstract] [Full Text] [Related]
2. [Bone destruction caused by osteoclasts]. Yamashita T, Takahashi N, Yang S, Sato N, Udagawa N. Clin Calcium; 2006 Feb; 16(2):234-40. PubMed ID: 16465024 [Abstract] [Full Text] [Related]
3. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts. Yang S, Takahashi N, Yamashita T, Sato N, Takahashi M, Mogi M, Uematsu T, Kobayashi Y, Nakamichi Y, Takeda K, Akira S, Takada H, Udagawa N, Furusawa K. J Immunol; 2005 Aug 01; 175(3):1956-64. PubMed ID: 16034140 [Abstract] [Full Text] [Related]
4. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Uehara A, Yang S, Fujimoto Y, Fukase K, Kusumoto S, Shibata K, Sugawara S, Takada H. Cell Microbiol; 2005 Jan 01; 7(1):53-61. PubMed ID: 15617523 [Abstract] [Full Text] [Related]
5. NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Correa-de-Santana E, Fröhlich B, Labeur M, Páez-Pereda M, Theodoropoulou M, Monteserin JL, Renner U, Stalla GK. J Endocrinol; 2009 Oct 01; 203(1):111-22. PubMed ID: 19608614 [Abstract] [Full Text] [Related]
6. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Takahashi N, Udagawa N, Suda T. Biochem Biophys Res Commun; 1999 Mar 24; 256(3):449-55. PubMed ID: 10080918 [Abstract] [Full Text] [Related]
7. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. J Bone Miner Res; 2000 Aug 24; 15(8):1459-66. PubMed ID: 10934644 [Abstract] [Full Text] [Related]
8. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, Kishimoto T, Nakanishi K, Fujimoto J. Hepatology; 2005 Mar 24; 41(3):443-50. PubMed ID: 15723296 [Abstract] [Full Text] [Related]
9. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Fritz JH, Girardin SE, Fitting C, Werts C, Mengin-Lecreulx D, Caroff M, Cavaillon JM, Philpott DJ, Adib-Conquy M. Eur J Immunol; 2005 Aug 24; 35(8):2459-70. PubMed ID: 16021602 [Abstract] [Full Text] [Related]
10. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Ojaniemi M, Glumoff V, Harju K, Liljeroos M, Vuori K, Hallman M. Eur J Immunol; 2003 Mar 24; 33(3):597-605. PubMed ID: 12616480 [Abstract] [Full Text] [Related]
11. Dual modulation of osteoclast differentiation by lipopolysaccharide. Zou W, Bar-Shavit Z. J Bone Miner Res; 2002 Jul 24; 17(7):1211-8. PubMed ID: 12096834 [Abstract] [Full Text] [Related]
12. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T. Nature; 2000 Nov 30; 408(6812):600-5. PubMed ID: 11117749 [Abstract] [Full Text] [Related]
13. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. Xiao XH, Zhou HD, Yuan LQ, Xie H, Liao EY. Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2102-6. PubMed ID: 15730627 [Abstract] [Full Text] [Related]
14. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neill LA. Nature; 2001 Sep 06; 413(6851):78-83. PubMed ID: 11544529 [Abstract] [Full Text] [Related]
15. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation. Wang C, Steer JH, Joyce DA, Yip KH, Zheng MH, Xu J. J Bone Miner Res; 2003 Dec 06; 18(12):2159-68. PubMed ID: 14672351 [Abstract] [Full Text] [Related]
16. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function]. Takahashi N. Clin Calcium; 2006 Jun 06; 16(6):940-47. PubMed ID: 16751689 [Abstract] [Full Text] [Related]
17. [Regulatory mechanism of bone resorption: roles of bone remodeling-regulatory cytokines 'osteokines' in osteoclast differentiation and function]. Kobayashi Y, Takahashi N. Nihon Rinsho; 2003 Feb 06; 61(2):200-6. PubMed ID: 12638208 [Abstract] [Full Text] [Related]
18. Peptidoglycan and lipopolysaccharide synergistically enhance bone resorption and osteoclastogenesis. Kishimoto T, Kaneko T, Ukai T, Yokoyama M, Ayon Haro R, Yoshinaga Y, Yoshimura A, Hara Y. J Periodontal Res; 2012 Aug 06; 47(4):446-54. PubMed ID: 22283724 [Abstract] [Full Text] [Related]
20. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways. Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C, Qiu W, Wu X, Wang X, Li H, Tang J, Qian M, Li D, Wang P, Luo J, Liu M. J Bone Miner Res; 2011 Mar 06; 26(3):644-56. PubMed ID: 20814972 [Abstract] [Full Text] [Related] Page: [Next] [New Search]